According to the new market research report “Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018”, the global Isothermal Nucleic Acid Amplification Technology (INAAT) Market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period.
The increasing demand for enhanced molecular testing using INAAT as well as rising incidence of infectious diseases is driving market growth over the conventional thermal polymerase chain reaction (PCR) technology.
In addition to increasing population suffering from infectious disease and cancer, promise for less expensive molecular testing using INAAT, better throughput in gene amplification, and advent of novel technologies such as Loop-Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA) and Helicase Dependent Amplification (HDA) play pivotal role in propelling market momentum. On the other hand, inadequate advanced infrastructure and higher dependency on convention method (PCR technology) restrict market growth globally.
Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=839
Amongst various applications of INAAT, prognosis and diagnosis of infectious disease allows a huge scope for market penetration of novel isothermal technologies such as Loop-Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA) and Helicase Dependent Amplification (HDA) among others. Infectious disease application market, especially sexually transmitted disease (STD) and hepatitis A & B, is expected to witness a double digit growth rate during the forecast period. Moreover, blood screening application is also expected to be a significant revenue pocket of INAAT due to increasing practice of mandatory testing of donated blood at blood donation unit to ensure the quality of blood sample.
End-users analysis identified reference laboratory as a potential segment ensuring a rapid growth of various isothermal amplification technologies in different complex molecular testing; whereas, technology roadmap analysis expected a rapid adoption of single miniaturized devices in the global molecular diagnostics industry.
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=839
The key players in the Isothermal Nucleic Acid Amplification Technology (INAAT) Market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252